Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Advancing precision medicine therapeutics for Parkinson’s utilizing a shared quantitative systems pharmacology model and framework

8 Mar 2024

Abstract excerpt

A rich pipeline of therapeutic candidates is advancing for Parkinson's disease, many of which are targeting the underlying pathophysiology of disease. Emerging evidence grounded in novel genetics and biomarker discoveries is illuminating the true promise of precision medicine-based therapeutic strategies for PD. There has been a growing effort to investigate disease-modifying therapies by designing clinical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Nuclear Receptors and Signaling
Share to Parkinson's Disease Mechanisms and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40809117
DOI: 10.3389/fsysb.2024.1351555

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Advancing precision medicine therapeutics for Parkinson’s utilizing a shared quantitative systems pharmacology model and frameworkPMID 40809117Read ↗

Disease‑Modifying Therapies for Parkinson’s Disease: Biological Mechanisms, Pharmacological Strategies, and Clinical PipelineSemantic proximity Read ↗

A network-based systems genetics framework identifies pathobiology and drug repurposing in Parkinson’s diseaseSemantic proximity Read ↗

Cohort-specific Boolean models highlight different regulatory modules during Parkinson’s disease progressionSemantic proximity Read ↗

Finding drug targeting mechanisms with genetic evidence for Parkinson’s diseaseSemantic proximity Read ↗

Challenges to the development of disease-modifying therapies in Parkinson's disease.Semantic proximity Read ↗

Hybrid modeling of Parkinsons disease integrating zebrafish neurobiology with in silico predictive analyticsSemantic proximity Read ↗

Precision medicine: Clarity for the clinical and biological complexity of Alzheimer's and Parkinson's diseases.Semantic proximity Read ↗

Parkinson's disease: From genetics to molecular dysfunction and targeted therapeutic approachesSemantic proximity Read ↗

Drug Repurposing for Parkinson’s Disease: A Large-Scale Multi-Cohort StudySemantic proximity Read ↗

Modeling Parkinson's Disease Heterogeneity to Accelerate Precision Medicine.Semantic proximity Read ↗

A Quantitative Systems Pharmacology Approach to Infer Pathways Involved in Complex Disease Phenotypes.Semantic proximity Read ↗

Precision medicine for disease modification in Parkinson diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.